Millennium Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-136,065
| Closed | -$4.07M | – | 6409 |
|
|
2025
Q4 | $5.2M | Buy |
136,065
+2,196
| +2% | +$71.4K | ﹤0.01% | 2967 |
|
|
2025
Q3 | $3.2M | Sell |
133,869
-75,122
| -36% | -$1.41M | ﹤0.01% | 3593 |
|
|
2025
Q2 | $3.09M | Buy |
208,991
+149,159
| +249% | +$2.47M | ﹤0.01% | 3469 |
|
|
2025
Q1 | $1.07M | Sell |
59,832
-566,224
| -90% | -$11.5M | ﹤0.01% | 4287 |
|
|
2024
Q4 | $10.9M | Buy |
626,056
+511,443
| +446% | +$9.05M | 0.01% | 2104 |
|
|
2024
Q3 | $1.6M | Sell |
114,613
-2,834,722
| -96% | -$29.5M | ﹤0.01% | 3908 |
|
|
2024
Q2 | $24.2M | Buy |
2,949,335
+747,406
| +34% | +$5.03M | 0.01% | 1329 |
|
|
2024
Q1 | $17M | Buy |
2,201,929
+907,343
| +70% | +$7.65M | 0.01% | 1697 |
|
|
2023
Q4 | $11.6M | Sell |
1,294,586
-2,058,795
| -61% | -$15M | 0.01% | 2041 |
|
|
2023
Q3 | $30M | Buy |
3,353,381
+2,728,778
| +437% | +$38.5M | 0.02% | 1086 |
|
|
2023
Q2 | $9.59M | Sell |
624,603
-499,735
| -44% | -$9.09M | ﹤0.01% | 2067 |
|
|
2023
Q1 | $25.3M | Buy |
1,124,338
+263,293
| +31% | +$5.6M | 0.01% | 1168 |
|
|
2022
Q4 | $18.1M | Buy |
861,045
+262,046
| +44% | +$5.55M | 0.01% | 1536 |
|
|
2022
Q3 | $14.8M | Buy |
598,999
+406,183
| +211% | +$10.5M | 0.01% | 1670 |
|
|
2022
Q2 | $4.67M | Sell |
192,816
-650,813
| -77% | -$16.4M | ﹤0.01% | 2877 |
|
|
2022
Q1 | $21.7M | Buy |
843,629
+553,326
| +191% | +$14.7M | 0.01% | 1309 |
|
|
2021
Q4 | $9.01M | Buy |
290,303
+126,355
| +77% | +$3.56M | ﹤0.01% | 2249 |
|
|
2021
Q3 | $3.98M | Buy |
163,948
+137,577
| +522% | +$2.53M | ﹤0.01% | 3134 |
|
|
2021
Q2 | $385K | Sell |
26,371
-409,311
| -94% | -$8.07M | ﹤0.01% | 5516 |
|
|
2021
Q1 | $10.9M | Sell |
435,682
-291,494
| -40% | -$8.05M | 0.01% | 1676 |
|
|
2020
Q4 | $19.8M | Sell |
727,176
-138,933
| -16% | -$3.24M | 0.01% | 1077 |
|
|
2020
Q3 | $16K | Sell |
866,109
-333,752
| -28% | -$6.49M | 0.02% | 930 |
|
|
2020
Q2 | $24.5M | Buy |
1,199,861
+71,987
| +6% | +$1.15M | 0.03% | 629 |
|
|
2020
Q1 | $16.5M | Sell |
1,127,874
-596,411
| -35% | -$8.97M | 0.04% | 545 |
|
|
2019
Q4 | $24.5M | Buy |
1,724,285
+1,209,501
| +235% | +$15.4M | 0.03% | 725 |
|
|
2019
Q3 | $5.97M | Sell |
514,784
-35,786
| -6% | -$591K | 0.01% | 1662 |
|
|
2019
Q2 | $11.1M | Buy |
550,570
+333,937
| +154% | +$6.59M | 0.02% | 1170 |
|
|
2019
Q1 | $4.9M | Sell |
216,633
-74,827
| -26% | -$1.65M | 0.01% | 1780 |
|
|
2018
Q4 | $6.6M | Sell |
291,460
-228,159
| -44% | -$5.68M | 0.01% | 1393 |
|
|
2018
Q3 | $14.9M | Sell |
519,619
-79,405
| -13% | -$2.27M | 0.02% | 1028 |
|
|
2018
Q2 | $16.3M | Sell |
599,024
-338,116
| -36% | -$9M | 0.02% | 991 |
|
|
2018
Q1 | $21M | Buy |
937,140
+378,880
| +68% | +$9.02M | 0.03% | 851 |
|
|
2017
Q4 | $11.8M | Buy |
558,260
+9,926
| +2% | +$227K | 0.02% | 1225 |
|
|
2017
Q3 | $13.6M | Buy |
548,334
+260,236
| +90% | +$5.73M | 0.02% | 1033 |
|
|
2017
Q2 | $5.59M | Sell |
288,098
-328,865
| -53% | -$5.96M | 0.01% | 1436 |
|
|
2017
Q1 | $11.4M | Sell |
616,963
-248,198
| -29% | -$4.86M | 0.02% | 949 |
|
|
2016
Q4 | $16.4M | Sell |
865,161
-330,817
| -28% | -$6.77M | 0.03% | 669 |
|
|
2016
Q3 | $26.8M | Buy |
1,195,978
+419,684
| +54% | +$7.99M | 0.04% | 458 |
|
|
2016
Q2 | $13.8M | Buy |
776,294
+433,464
| +126% | +$7.02M | 0.03% | 689 |
|
|
2016
Q1 | $4.68M | Sell |
342,830
-140,469
| -29% | -$2.13M | 0.01% | 1289 |
|
|
2015
Q4 | $9.32M | Buy |
483,299
+21,165
| +5% | +$423K | 0.02% | 962 |
|
|
2015
Q3 | $9.36M | Sell |
462,134
-367,440
| -44% | -$10.9M | 0.02% | 970 |
|
|
2015
Q2 | $27.5M | Sell |
829,574
-110,828
| -12% | -$3.04M | 0.05% | 477 |
|
|
2015
Q1 | $22.5M | Buy |
+940,402
| New | +$14.3M | 0.04% | 603 |
|
|
2014
Q2 | – | Sell |
-25,700
| Closed | -$545K | – | 3891 |
|
|
2014
Q1 | $545K | Buy |
+25,700
| New | +$395K | ﹤0.01% | 2570 |
|
Other funds holding TVTX
AC
PA
VCM
NAMI
Millennium Management's TVTX Position: Q1 2026 in Review
Millennium Management sold out of Travere Therapeutics (TVTX) in Q1 2026, closing a stake of 136,065 shares — an estimated $4.07M sold.
Millennium Management first reported a position in TVTX in Q1 2014 and held it in 45 quarters. The position peaked at $30M in Q3 2023. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.
- Millennium Management reported no remaining Travere Therapeutics position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 136,065 Travere Therapeutics shares in Q1 2026, an estimated $4.07M.
- Millennium Management first reported a position in Travere Therapeutics in Q1 2014 and held it in 45 quarters.
- Millennium Management's Travere Therapeutics position peaked at $30M in Q3 2023.
- 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.